These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 3699091
1. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions. Saller CF, Salama AI. Eur J Pharmacol; 1986 Feb 18; 121(2):181-8. PubMed ID: 3699091 [Abstract] [Full Text] [Related]
3. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. Koch SW, Koe BK, Bacopoulos NG. Eur J Pharmacol; 1983 Sep 02; 92(3-4):279-83. PubMed ID: 6138267 [Abstract] [Full Text] [Related]
4. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat. Borawska M, Wiśniewski K. Pol J Pharmacol Pharm; 1982 Sep 02; 34(1-3):79-84. PubMed ID: 7167424 [Abstract] [Full Text] [Related]
5. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL. Biochem Pharmacol; 1990 Aug 01; 40(3):417-23. PubMed ID: 2383279 [Abstract] [Full Text] [Related]
6. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment. Nomura Y, Komori T, Okuda S, Segawa T. Arch Int Pharmacodyn Ther; 1979 Jan 01; 237(1):25-30. PubMed ID: 485682 [Abstract] [Full Text] [Related]
7. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration. Tissari AH, Lillgäls MS. J Neurochem; 1993 Jul 01; 61(1):231-8. PubMed ID: 8099951 [Abstract] [Full Text] [Related]
8. Dual effects of nicotine on neuroleptic-induced changes of striatal dopamine metabolism in mice. Haikala H. Pharmacol Toxicol; 1989 Apr 01; 64(4):334-9. PubMed ID: 2568630 [Abstract] [Full Text] [Related]
9. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions. Bacopoulos NG, Roth RH. Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869 [Abstract] [Full Text] [Related]
10. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation. Magnusson O, Mohringe B, Fowler CJ. J Neural Transm; 1987 Feb 02; 69(3-4):163-77. PubMed ID: 2957465 [Abstract] [Full Text] [Related]
11. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin. Olgiati VR, Algeri S, Stramentinoli G. Pharmacol Res Commun; 1987 Mar 02; 19(3):231-40. PubMed ID: 3602044 [Abstract] [Full Text] [Related]
12. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment. Kuczenski R, Leith NJ, Applegate CD. Brain Res; 1983 Jan 10; 258(2):333-7. PubMed ID: 6824917 [Abstract] [Full Text] [Related]
13. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content. Saller CF, Salama AI. J Neurochem; 1984 Sep 10; 43(3):675-88. PubMed ID: 6747629 [Abstract] [Full Text] [Related]
18. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL. Mol Pharmacol; 1990 Jul 10; 38(1):92-101. PubMed ID: 1973525 [Abstract] [Full Text] [Related]
19. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum. Walters DE, Howard SG. Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376 [Abstract] [Full Text] [Related]